Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing.
- DOI
- 10.1016/j.redox.2026.104229
- Published
- 2026 Sep
- Container
- Redox biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.redox.2026.104229,
title = {Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing.},
author = {Ali T and Ponnamperumage TNF and Miller CJ and Li D and Awoyera WO and Peterson AK and Gao H and Pandey J and Jakusz JAR and Fan H and Koelsch GE and Arnold LA and Jorns JM and Cheng YC and Roy A and Zhou G and Peng X},
year = {2026},
journal = {Redox biology},
doi = {10.1016/j.redox.2026.104229},
url = {https://doi.org/10.1016/j.redox.2026.104229}
}RIS
TY - JOUR TI - Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing. AU - Ali T AU - Ponnamperumage TNF AU - Miller CJ AU - Li D AU - Awoyera WO AU - Peterson AK AU - Gao H AU - Pandey J AU - Jakusz JAR AU - Fan H AU - Koelsch GE AU - Arnold LA AU - Jorns JM AU - Cheng YC AU - Roy A AU - Zhou G AU - Peng X PY - 2026 JO - Redox biology DO - 10.1016/j.redox.2026.104229 UR - https://doi.org/10.1016/j.redox.2026.104229 ER -
APA
T, A., TNF, P., CJ, M., D, L., WO, A., AK, P., H, G., J, P., JAR, J., H, F., GE, K., LA, A., JM, J., YC, C., A, R., G, Z., & X, P. (2026). Exploiting vitamin C as a prooxidant to activate ROS-responsive prodrugs for potent and selective tumor killing.. Redox biology. https://doi.org/10.1016/j.redox.2026.104229
Source records
- pubmed · retrieved 2026-09-25T21:40:41.131Z